Zyloric /00003301/


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 25.0%
Diabetes Mellitus 15.6%
Coronary Artery Bypass 12.5%
Asthma 9.4%
Type 2 Diabetes Mellitus 9.4%
Hypertension 6.3%
Acute Pulmonary Oedema 3.1%
Arrhythmia 3.1%
Blood Uric Acid Increased 3.1%
Complex Regional Pain Syndrome 3.1%
Coronary Artery Disease 3.1%
Hypercholesterolaemia 3.1%
Hyperthermia 3.1%
Drug Rash With Eosinophilia And Systemic Symptoms 33.3%
Rash Generalised 25.0%
Erythema Multiforme 8.3%
Lichenoid Keratosis 8.3%
Myeloproliferative Disorder 8.3%
No Adverse Event 8.3%
Tricuspid Valve Incompetence 8.3%
Concomitant
Multiple Myeloma 19.1%
Product Used For Unknown Indication 10.9%
Prophylaxis 9.2%
Hypertension 8.2%
Plasma Cell Myeloma 6.7%
Type 2 Diabetes Mellitus 6.5%
Drug Use For Unknown Indication 5.1%
Hyperuricaemia 5.1%
Amyloidosis 3.8%
Cardiac Amyloidosis 3.8%
Benign Prostatic Hyperplasia 3.0%
Constipation 2.8%
Diabetes Mellitus 2.8%
Insulin-requiring Type Ii Diabetes Mellitus 2.4%
Type 1 Diabetes Mellitus 2.3%
Hyperphosphataemia 1.8%
Pain 1.8%
Hyperlipidaemia 1.7%
Insomnia 1.6%
Hyperparathyroidism Secondary 1.3%
Thrombocytopenia 11.7%
Dizziness 9.1%
Diabetic Ketoacidosis 7.8%
Hypoglycaemia 7.8%
Renal Failure Acute 6.5%
Malaise 5.2%
Renal Failure 5.2%
Ventricular Tachycardia 5.2%
Wheezing 5.2%
Acute Myocardial Infarction 3.9%
Hepatic Function Abnormal 3.9%
Hypoglycaemic Coma 3.9%
Platelet Count Decreased 3.9%
Respiratory Failure 3.9%
Vomiting 3.9%
Angina Pectoris 2.6%
Eyelid Oedema 2.6%
Gastrointestinal Haemorrhage 2.6%
Injection Site Reaction 2.6%
Interstitial Lung Disease 2.6%

Drug Data